[1] 宁宇, 李波, 方芳, 等. 人口老龄化与老年人口健康及疾病问题的研究进展[J].吉林大学学报(医学版), 2008, 34(6):1102-1105. [2] MACARI S, DUFFLES L F, QUEIROZ-JUNIOR C M, et al. Oestrogen regulates bone resorption and cytokine production in the maxillae of female mice[J]. Arch Oral Biol, 2015, 60(2):333-341. [3] LAMONTE M J, HOVEY K M, GENCO R J, et al. Five-year changes in periodontal disease measures among postmenopausal females:the Buffalo OsteoPerio study[J]. J Periodontol, 2013, 84(5):572-584. [4] KONG Y Y, FEIGE U, SAROSI I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand[J]. Nature, 1999, 402(6759):304-309. [5] TENG Y T, NGUYEN H, GAO X, et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection[J]. J Clin Invest, 2000, 106(6):R59-R67. [6] WEITZMANN M N. Bone and the immune system[J]. Toxicol Pathol, 2017, 45(7):911-924. [7] EISENSTEIN E M, WILLIAMS C B. The T(reg)/Th17 cell balance:a new paradigm for autoimmunity[J]. Pediatr Res, 2009, 65(5 Pt 2):26R-31R. [8] CARDOSO C R, GARLET G P, CRIPPA G E, et al. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease[J]. Oral Microbiol Immunol, 2009, 24(1):1-6. [9] CAFFERATA E A, TERRAZA-AGUIRRE C, BARRERA R, et al. Interleukin-35 inhibits alveolar bone resorption by modulating the Th17/Treg imbalance during periodontitis[J]. J Clin Periodontol, 2020, 47(6):676-688. [10] LYNCH S V, PEDERSEN O. The human intestinal microbiome in health and disease[J]. N Engl J Med, 2016, 375(24):2369-2379. [11] NILSSON A G, SUNDH D, BÄCKHED F, et al. Lactobacillus reuteri reduces bone loss in older women with low bone mineral density:a randomized, placebo-controlled, double-blind, clinical trial[J]. J Intern Med, 2018, 284(3):307-317. [12] CHEN L L, ZOU Y Y, PENG J, et al. Lactobacillus acidophilus suppresses colitis-associated activation of the IL-23/Th17 axis[J]. J Immunol Res, 2015, 2015:909514. [13] MOLNÁR I, BOHATY I, SOMOGYINÉ-VÁRIÉ. IL-17A-mediated sRANK ligand elevation involved in postmenopausal osteoporosis[J]. Osteoporos Int, 2014, 25(2):783-786. [14] GAFFEN S L, HAJISHENGALLIS G. A new inflammatory cytokine on the block:re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17[J]. J Dent Res, 2008, 87(9):817-828. [15] LUBBERTS E, VAN DEN BERSSELAAR L, OPPERS-WALGREEN B, et al. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance[J]. J Immunol, 2003, 170(5):2655-2662. [16] LIU H R, LUO T T, TAN J L, et al. ‘osteoimmunology’ offers new perspectives for the treatment of pathological bone loss[J]. Curr Pharm Des, 2017, 23(41):6272-6278. [17] LI R, TIAN C, POSTLETHWAITE A, et al. Rheumatoid arthritis and periodontal disease:What are the similarities and differences?[J]. Int J Rheum Dis, 2017, 20(12):1887-1901. [18] YU J J, RUDDY M J, CONTI H R, et al. The interleukin-17 receptor plays a gender-dependent role in host protection against Porphyromonas gingivalis-induced periodontal bone loss[J]. Infect Immun, 2008, 76(9):4206-4213. [19] YU J J, RUDDY M J, WONG G C, et al. An essential role for IL-17 in preventing pathogen-initiated bone destruction:recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals[J]. Blood, 2007, 109(9):3794-3802. [20] SHREINER A B, KAO J Y, YOUNG V B. The gut microbiome in health and in disease[J]. Curr Opin Gastroenterol, 2015, 31(1):69-75. [21] 陈爽,吴静,达静静,等.益生菌对66例腹膜透析患者蛋白质-能量消耗和微炎症状态的作用研究[J].中国实用内科杂志,2019,38(12):260-264. [22] ZHANG J, LU Y Q, WANG Y Z, et al. The impact of the intestinal microbiome on bone health[J]. Intractable Rare Dis Res, 2018, 7(3):148-155. [23] FOSSIEZ F, DJOSSOU O, CHOMARAT P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines[J]. J Exp Med, 1996, 183(6):2593-2603. [24] WANG J H, WANG Y Y, GAO W J, et al. Diversity analysis of gut microbiota in osteoporosis and osteopenia patients[J]. Peer J, 2017, 5:e3450. [25] 张颜廷,JACOBY J J, 王静, 等. 益生菌制剂对钙缺乏骨质疏松症的防治作用[J]. 中国骨质疏松杂志, 2016, 22(1):45-48. [26] IKRAM S, HASSAN N, RAFFAT M A, et al. Systematic review and meta-analysis of double-blind, placebo-controlled, randomized clinical trials using probiotics in chronic periodontitis[J]. J Investig Clin Dent, 2018, 9(3):e12338. [27] RIGGS B L. The mechanisms of estrogen regulation of bone resorption[J]. J Clin Invest, 2000, 106(10):1203-1204. [28] MOHAMMAD I, STARSKAIA I, NAGY T, et al. Estrogen receptor α contributes to T cell-mediated autoimmune inflammation by promoting T cell activation and proliferation[J]. Sci Signal, 2018, 17(4):11. [29] KARPUZOGLU E, ZOUALI M. The multi-faceted influences of estrogen on lymphocytes:toward novel immuno-interventions strategies for autoimmunity management[J]. Clin Rev Allergy Immunol, 2011, 40(1):16-26. [30] 王中秀, 陈莉丽. 辅助性T细胞1和17特征性分泌因子干扰素γ及白细胞介素17在牙周炎发生发展中作用的研究进展[J]. 中华口腔医学杂志, 2019, 54(6):420-424. [31] SRIVASTAVA R K, DAR H Y, MISHRA P K. Immunoporosis:immunology of osteoporosis-role of T cells[J]. Front Immunol, 2018, 9:657. [32] DUTZAN N, KAJIKAWA T, ABUSLEME L, et al. A dysbiotic microbiome triggers Th17 cells to mediate oral mucosal immunopathology in mice and humans[J]. Sci Transl Med, 2018, 10(463):eaat0797. |